Breast cancer. Z58.3
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Sexual Activity: Individuals must be sexually active (as per self-report) in the last three months. Age Range: Participants should be between the ages of 20 and 50 years. Mental Health History: Participants must have a history of mental illness within the last year, evidenced by at least one of the following:A visit to a psychiatrist.The need to take psychiatric medication (as per individual report). Vaginal Atrophy: Presence of vaginal atrophy, confirmed through a vaginal examination and diagnosed by a qualified gynecologist.Willingness to Participate: Participants must express a willingness to participate in the study. Pregnancy Status: Participants must not be pregnant at the time of the study. Commitment to the Study: Participants must be willing to continue cooperation throughout the study duration. Not having other cancers at the same time Literacy Requirement: Participants must possess at least basic reading and writing skills necessary for completing questionnaires
Exclusion criteria
Exclusion criteria: Discontinuation of Interest: Participants who express a desire to discontinue their participation in the study. Pregnancy: Participants who become pregnant during the course of the study. Non-compliance with Medication: Participants who do not adhere to the prescribed medication regimen. Recurrent Illness: Participants who experience a recurrence of the illness being studied during the course of the study, whether self-reported or resulting in hospitalization. Hospitalization During Intervention: Participants who are hospitalized for any reason during the intervention phase of the study. Initiation of Psychiatric Drug Treatments: Participants who begin psychiatric drug treatments during the study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effect of Vitamin E gel and Malva Neglecta herbal gel on the treatment of vaginal atrophy, sexual satisfaction, and sexual quality of life of women with breast cancer. Timepoint: 4,8,12 weeks. Method of measurement: SQOL-F, Enrich. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the frequency of sexual activity. Timepoint: ,4, 8,12. Method of measurement: self report. | — |
Countries
Iran (Islamic Republic of)
Contacts
Zanjan University of Medical Sciences